. Author manuscript; available in PMC: 2011 Mar 29.

Published in final edited form as: Ann Surg Oncol. 2009 Feb 5;16(4):836–847. doi: 10.1245/s10434-008-0295-2

TABLE 3.

Timing and first site or sites of recurrent disease in 21 five-year survivors whose disease recurred

Patient No.	Site of first recurrence	Time to recurrence (months)	Recurrence to last follow-up (months)	Overall survival (months)	Current status
1	Lung^a	10	54	64	DWD
2	Liver	12	56	68	DWD
3	Locoregional^a	13	47	60	DWD
4	Lung^a	16	57	73	DWD
5	Brain^a	21	114	135	DOC
6	Abdominal wall^a	25	41	66	AWD
7	Liver, lung	29	37	66	DWD
8	Liver^a	42	23	65	DWD
9	Locoregional^a	43	27	69	DWD
10	Lung^a	47	23	70	AWD
11	Lung^a	49	20	69	DWD
12	Lung^a	57	9	65	AWD
13	Lung	57	3	60	DWD
14	Peritoneum^a	58	7	65	DWD
15	Lung^a	70	15	85	DWD
16	Lung^a	71	1	71	DWD
17	Dermis^a	71	1	73	DWD
18	Lung^a	76	12	88	DWD
19	Lung^a	78	12	91	DWD
20	Lung,^a Peritoneum	80	4	83	DWD
21	Lung^a	80	11	91	DWD

DWD dead with disease, DOC dead of other cause, AWD alive with disease

Histopathologically verified